Advertisement.

NTII Projected Dividend Yield

Neurobiological Technologies, Inc. ( OTCBB : NTII )

Neurobiological Technoligies has interest in an investigational drug called XERECEPT®, which is a synthetic preparation of Corticotropin-Releasing Factor, a natural human peptide. XERECEPT® is being developed by Celtic Pharma as a treatment for swelling around brain tumors and other cancer indications. Co. is entitled to receive payments for development and commercialization of XERECEPT by Celtic Pharma.

25 YEAR PERFORMANCE RESULTS

NTII Dividend History Detail
NTII Dividend News
NTII Competitors News

# of Shares: 0

Closing Price: 0.00

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2009	0.93	0%	0	$ 0.00	0.00%
2010	0.00	0%	0	$ 0.00	0.00%
2011	0.00	0%	0	$ 0.00	0.00%
2013	0.00	0%	0	$ 0.00	0.00%
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000